Dr Reddys Laboratories Share Price Today - Live Blog for September 15, 2025

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.09%, and as of now, it's trading at ₹1,301.85 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at ₹1,301.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.1600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.04% drop, and it's now trading at ₹1,301.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd remained consistent, showing no variations, and is currently at ₹1,301.00. Investors may choose to delve into the stock's financial health and competitive positioning.

Dr Reddys Laboratories Ltd's share price remained flat, currently at ₹1,301.00. This sustained performance provides investors with an opportunity to assess whether the stock aligns with their investment objectives.

Following a noteworthy 0.12% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,301.50. When it comes to valuation, this stock has a PE ratio of 19.1600, with the industry PE ratio at 34.9780.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.12% increase and currently trading at ₹1,301.50 per share. Investors are taking notice of this upward momentum.

After a notable 0.18% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,299.60. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd share price surged by 0.13%. With its current market price standing at ₹1,297.60 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's share price has dropped by -0.37%, a development that warrants careful analysis. Presently trading at ₹1,296.00, investors are assessing whether this presents an opportunity or a risk.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.09% gain, with the share price now at ₹1,300.80. Notably, the stock's PE ratio stands at 19.1600, and its Return on Equity (ROE) is 16.8559%.

With a remarkable 0.06% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,300.75. Notably, this stock has a Price-to-Earnings (PE) ratio of 19.1600, while the industry's PE ratio is 34.9780.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.06% recently. As of now, this stock is actively trading at a current market price of ₹1,300.75 per share, attracting attention from investors.

The share price of Dr Reddys Laboratories Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,299.80, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.09% increase. Presently, it is actively trading at ₹1,299.15.

Following a noteworthy 0.09% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,299.15. When it comes to valuation, this stock has a PE ratio of 19.1600, with the industry PE ratio at 34.9780.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.35% recently. As of now, this stock is actively trading at a current market price of ₹1,298.75 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,295.25 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd shares saw a -0.11% decrease, reaching a current market price of ₹1,294.85. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.1600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.20% downturn in its share price, and it's currently trading at ₹1,297.00. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd experienced a -0.13% downturn in its share price, and it's currently trading at ₹1,299.50. This situation is generating interest among value investors who are evaluating the stock's potential.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.19%. At this moment, it's actively trading at ₹1,300.50, presenting an enticing opportunity for those in the market.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.02%, signalling a challenging period. Currently trading at ₹1,295.75, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,295.75. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.1600, while the industry PE is 34.9780.

Dr Reddys Laboratories Ltd shares saw a -0.06% decrease, reaching a current market price of ₹1,296.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.1600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a -1.64% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,294.75. The stock has a PE ratio of 19.1600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.